<DOC>
	<DOCNO>NCT01001312</DOCNO>
	<brief_summary>Heart failure common cardiac condition affect nearly 6 million Americans . Silent blood volume overload common patient heart failure associate increase risk death . This study design determine adjustment therapy base direct measurement blood volume reduce risk hospitalization death compare therapy base clinical assessment blood volume patient chronic heart failure .</brief_summary>
	<brief_title>Safety Efficacy Direct Blood Volume Measurement Treatment Heart Failure</brief_title>
	<detailed_description>Multicenter prospective randomize trial compare heart failure management strategy base clinical assessment volume status vs. direct measurement blood volume radioisotope technique . Subjects randomly assign standard care strategy guideline recommend treatment base serial clinical assessment blood volume measure blood volume strategy guideline recommend treatment base serial measure blood volume . All subject undergo blood volume measurement procedure , test result return physician group assign management accord measure blood volume status . Subjects blind study treatment assignment status .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Age &gt; 21 year Discharge hospital emergency department observation unit primary diagnosis acute decompensated heart failure Planned discharge home Able willing provide inform consent Significant comorbidity heart failure hospitalization ( treat pneumonia , sepsis , respiratory failure , oliguric renal failure , major bleed require transfusion , stroke ) Heart failure primarily due significant valvular disease , subaortic outflow obstruction , active myocardial ischemia , apical ballooning syndrome , active arrhythmia , active myocarditis , primary restrictive cardiomyopathy , pericardial disease , congenital heart disease Other major comorbidities increase mortality risk ( stroke hemiplegia , diabetes endorgan damage heart disease , history cancer last 2 year , moderate severe liver disease , HIV infection AIDS ) Hospitalization length stay &gt; 10 day Evidence acute coronary syndrome qualify heart failure hospitalization Planned revascularization procedure within 6 month Planned implantation ICD pacemaker within 6 month Planned placement cardiac transplantation list within 6 month Planned major cardiac surgery surgery within 6 month Planned intermittent continuous intravenous positive inotropic therapy Planned intermittent continuous intravenous vasodilator therapy Severe obesity ( BMI ≥ 40 kg/m2 ) cachexia ( BMI ≤18 kg/m2 ) Severe chronic kidney disease ( estimate GFR &lt; 30 ml/min ( Modification Diet Renal Disease formula20 ) ) Hemoglobin &lt; 10 gm/dl Noncardiac primary limitation exercise ( rheumatological , orthopedic , pulmonary , neurological peripheral vascular disease ) Known history nonadherence medication Psychosocial factor interfere ability adhere study procedure ( dementia , active substance abuse , poorly control psychiatric illness , inability travel frequently study center ) Pregnant woman nurse mother Women childbearing potential use adequate birth control method Known hypersensitivity iodine , egg , component Volumex injection kit History anaphylaxis Participation another heart failure investigational treatment protocol currently &lt; 30 day</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Therapeutics</keyword>
	<keyword>Blood volume</keyword>
</DOC>